cobas® i 601 analyzer
Enter a new dimension in mass spectrometry
With the cobas® Mass Spec solution, which includes the cobas® i 601 analyzer and the Ionify® reagents line, you can step away from tedious and complex manual mass spectrometry workflows and experience the simplicity and convenience of a streamlined end-to-end solution.
From sample preparation to result interpretation, Roche will be consolidating four technologies onto a single platform—ISE, clinical chemistry, immunochemistry, and mass spectrometry—maximizing efficiency and delivering enhanced medical value.* Our solution is designed to enable smart testing through seamless physical and digital connectivity with other analytical units.
A broad assay menu of Ionify reagents is in development, complementing the clinical chemistry and immunoassay portfolio available on cobas® pro integrated solutions. The assays include ready-for-use test kits with consistent performance and traceability to reference methods.
Enhance your lab’s capabilities by complementing existing methodologies and expanding services to new patient populations and disease areas with mass spectrometry.1-3 The cobas® i 601 analyzer allows you to streamline current workflows that require dedicated and specialized staff.
Related products
*At launch, cobas Mass Spec will be in a stand-alone configuration only. All other configurations, including clinical chemistry and immunochemistry analytical units, will be available at a later date.
**Please contact your local representative to confirm the current availability of the cobas® i 601 analytical unit, specific Ionify reagents, and their regulatory status in your region.
†Integration with cobas® pro is not currently available for sale in the US.
‡Manual sample pre-treatment is still required for certain assays (e.g., immunosuppressant drugs and free drugs).
References:
- Grebe SK, Singh RJ. LC-MS/MS in the Clinical Laboratory - Where to From Here? Clin Biochem Rev. 2011;32(1):5-31.
- Hristova J & Svinarov D. Enhancing precision medicine through clinical mass spectrometry platform. Biotechnology & Biotechnological Equipment. 2022;36(1):107-117.
- Ketha SS, Singh RJ, Ketha H. Role of Mass Spectrometry in Clinical Endocrinology. Endocrinol Metab Clin North Am. 2017;46(3):593-613.